Lumefantrine Unknown Status Phase 4 Trials for Helminthiasis / Plasmodium Infections / Change in Sustained Attention / schistosoma infection / Anemia Prevention

Indications	Status	Purpose	Phase
DBCOND0028088 (Helminthiasis) DBCOND0034555 (Plasmodium Infections) DBCOND0054556 (Change in Sustained Attention) DBCOND0022683 (schistosoma infection) DBCOND0020261 (Anemia)	Unknown Status	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
https://clinicaltrials.gov/ct2/show/	Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana	Albendazole (DB00518) Artemether (DB06697) Lumefantrine (DB06708) Praziquantel (DB01058)